- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Recombinant mouse CD206 (MMR)
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
- Preparation
- The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421? under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
ICFC - Quality tested
FC, IHC-F - Verified
SB - Reported in the literature, not verified in house
- Recommended Usage
Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?L?per million cells in 100 ?L?staining volume or 5 ?L?per 100 ?L?of whole blood. For immunohistochemistry on frozen tissue sections, a concentration range of 2.5 - 5.0 ?g/mL?is suggested. It is recommended that the reagent be titrated for optimal performance for each application.
Brilliant Violet 421? excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421? is a trademark of Sirigen Group Ltd.
Learn more about Brilliant Violet?.
This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents. - Excitation Laser
- Violet Laser (405 nm)
- Application Notes
Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.
- Additional Product Notes
Iterative Bleaching Extended multi-pleXity (IBEX) is a fluorescent imaging technique capable of highly-multiplexed spatial analysis. The method relies on cyclical bleaching of panels of fluorescent antibodies in order to image and analyze many markers over multiple cycles of staining, imaging, and, bleaching. It is a community-developed open-access method developed by the Center for Advanced Tissue Imaging (CAT-I) in the National Institute of Allergy and Infectious Diseases (NIAID, NIH).
- Application References
(PubMed link indicates BioLegend citation) -
- Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
- Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
- Yang X, et al. 2015. PNAS. 112:2900. PubMed
- Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
- Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
- Product Citations
-
- Trofimova O, et al. 2021. Vaccines (Basel). 9:. PubMed
- Conforti A, et al. 2021. PLoS One. 16:e0259894. PubMed
- Vicario N, et al. 2021. Cell Death Disease. 12(7):625. PubMed
- Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
- Simonneau M, et al. 2018. Oncotarget. 9:36457. PubMed
- Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
- Ayoub M, et al. 2019. Sci Rep. 9:6348. PubMed
- Das LM, et al. 2019. Autophagy. 15:813. PubMed
- Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
- Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
- Yang P, et al. 2022. Nat Commun. 13:5782. PubMed
- Kimbrough D, et al. 2018. J Mol Cell Cardiol. 119:51. PubMed
- Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed
- Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
- Giampazolias E, et al. 2021. Cell. . PubMed
- Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
- Parigiani MA, et al. 2020. Cancers (Basel). 12:00. PubMed
- Ito F, et al. 2015. PLoS One. 10: 0143370. PubMed
- Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
- Yang N, et al. 2021. NPJ Precis Oncol. 5:37. PubMed
- Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
- RRID
- AB_2562232 (BioLegend Cat. No. 141717)